Paulis, L. E., Klein, A. M., Ghanem, A., Geelen, T., Coolen, B. F., Breitbach, M., . . . Strijkers, G. J. (2013). Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Paulis, Leonie E., et al. Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-term Survival. Public Library of Science (PLoS), 2013.
Cita MLA (8a ed.)Paulis, Leonie E., et al. Embryonic Cardiomyocyte, but Not Autologous Stem Cell Transplantation, Restricts Infarct Expansion, Enhances Ventricular Function, and Improves Long-term Survival. Public Library of Science (PLoS), 2013.